Gene Editing
Market Research Report, By Methods (Crispr, Talen, Zfn, Antisense Technology
And Others), By Applications (Plant Genetic Engineering, Animal Genetic
Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User
(Biotechnology, Pharmaceutical, Contract Research Organization) – Global
Forecast Till 2023
Overview:
The Gene-Editing
Market Forecast is fast gaining leverage from
various end user industries owing to which growth would be substantial in the
coming years. The forecast period of 2018 to 2023 is all set to witness a
substantial hike in the CAGR. Market Research Future (MRFR) discussed the
growing demands from pharmaceutical industries for better-personalized
medicines, improved diagnostic methods, and swifter treatments, hike in its use
in agriculture to develop better crops, and others as possible growth-inducing
factors.
Get a Free
Sample @
https://www.marketresearchfuture.com/sample_request/707
On the flip
side, it raises some ethical questions which can deter the gene-editing market
growth. However, its growing inclusion will get it back on track.
Competitive Landscape:
The global gene
editing market would depend substantially on various strategies launched by
companies like Horizon Discovery Group plc (U.K.), GenScript USA Inc. (U.S.),
Lonza Group Ltd. (Switzerland), Integrated DNA Technologies, Inc. (U.S.),
OriGene Technologies, Inc. (U.S.), New England Biolabs, Inc. (U.S.),
Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.),
Sangamo Biosciences, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc.
(U.S.).
Segmentation:
·
Analysts from MRFR have studied
the global gene editing market on the basis of method, application, and end user.
Inputs and insights from these segments are expected to help the global market
in deciding how the market can be shaped in the coming years.
·
By methods, the gene-editing
market can be segmented on the basis of CRISPR, TALEN, ZFN, Antisense
technology and others.
·
By application, the gene
editing market can be segmented on the basis of animal genetic engineering,
microorganism’s genetic engineering plant genetic engineering, and gene
therapy.
·
By end user, the gene editing
market report has been segmented on the basis of biotechnology, pharmaceuticals
and contract research organizations.
Regional Analysis:
The global gene
editing market is all set to benefit from the contributions made by the
Americas. The regional market is set to profit from the research activities in
North America where the US and Canada would be playing prominent roles. These
countries are known for their superlative facilities that include a top-class
infrastructure and reliable influx in investment for various drug-related
projects. The regional pharmaceutical industries are thriving and their growth
would be bolstered by initiatives taken by both private and public
organizations. In Europe, the global market would benefit from the
contributions made by major countries like France, Italy, Germany, the UK, and
others. These countries share the same prospects like that of the US and Canada.
In the Asia
Pacific region, various countries like India, China, Japan, South Korea,
Australia, and others would create much demand for the gene editing segment.
This is to substantially back the increasing demand from the regional
healthcare market. Hike in disposable income is creating a demand for more
personalized drugs and better inclusion of gene editing in the agricultural
sector to develop better-quality products.
Industry News:
In February
2020, Biogen and Sangamo announced that they are joining hands to develop
better gene-editing technologies in a bid to treat diseases like Parkinson’s
and Alzheimer’s. Both these diseases are known for their impact on human
nerves.
In February
2020, Bill Gates also advocated in favor of the use of gene editing and
artificial intelligence in the healthcare sector. This would inspire investors
in contributing more funds to develop a better market stand.
NOTE : Our team of researchers
are studying Covid19 and its impact on various industry verticals and
wherever required we will be considering covid19 footprints for a
better analysis of markets and industries. Cordially get in touch for more
details.
Comments
Post a Comment